Research

The efficacy and safety of FulFix® has been tested and scientifically proven using the final product. Several independent clinical tests have proven that after 2 months use, FulFix® reduced hair loss in 98.7% and increased hair growth in 92.9% of participants.

Developed by leading researchers, this product has been tried and tested in extensive clinical trials and shown to produce unprecedented results and unmatched efficacy in curing baldness and stimulating hair growth.

Medical efficacy testing based on clinical trials conducted with 758 participants (482 men and 276 women) showed 95.1 % positive results.

In 98.7% of the cases, hair loss was successfully stopped

In 99.3% of the cases, new hair regrowth was observed

In 92.9% of the cases, graying processes were stopped and the newly grown hair was the original color

Research1

Clinically Proven Hair Loss Treatment

FulFix® is based on more than 20 years of scientific research.

Dr. A. Chan, a highly recognized American Dermatologist, has been studying the effects of various compounds and herbs on hair loss and hair growth for more than 20 years. She has conducted numerous clinical researches focused on finding and developing an effective cure for baldness. The results she gathered in the course of her in-depth medical trials and scientific testings made possible the creation of an unprecedented baldness treatment – a serum consisting of rare herbal extracts and a powerful amino-acid complex that practically puts and end to hair fall, unlocks hair re-growth, and prevents graying processes.

The truth?

Scientifically speaking, no hair loss treatment program has achieved so eloquent clinical results. Until now.

In April and May, 2012, 276 women and 482 men participated in a single-blind clinical trial on examining the effects of FulFix® on treating hair loss and stimulating hair growth. They had FulFix® applied to their hair roots twice a week. All of them were suffering of some sort of baldness – from mild hair thinning to scarring alopecia – a severe hair growth disorder that destroys the hair follicle, replaces it with scar tissue, and causes permanent and irreversible hair loss.

None of those 758 people knew whether they were having the product or a placebo applied to their scalps. The researchers were informed, though, and they were measuring the results. A control group of 163 people amongst those 758, didn't have FulFix® rubbed into their hair roots, and they had a placebo product administered to their scalps instead.. They didn't knew what are they were treated with, too.

In such in-depth clinical trials on medical solutions and disease treatments, it is absolutely compulsory to have a control group. Thus, researchers can compare the results achieved with a placebo treatment to those from the test group treated with the actual medication, and decide if and to what extent the product is medically active. This is necessary for the scientists to determine whether the test product is really effective or its effectiveness is partly due to false results stemming from psychological expectations.

Researchers estimated the extent of baldness of each participant first at the beginning of the study, and then again at the end of the study. The participants in the test group that had FulFix® administered to their scalps had an average of 98.7% hair loss reduction rate and 99.3% new hair growth rate. Those 163 people tested in the control group and treated with a placebo had an average of 8.5% hair loss aggravation and were continuing to lose hair in a rapid pace.

Two months later a double-blind placebo-controlled study followed. Double-blinded studies reduce the chance of manipulating results in order to show the product in a better light. That second clinical trial was conducted by an independent laboratory with 245 male and 176 female participants that were separated into two groups – one had FulFix® administered to their scalps and the other was treated with a placebo. Neither of the groups was aware of what they were having applied to their hair. The researchers didn't knew as well which group was treated with FulFix® and which – with a placebo solution. There was a group of independent supervisors that were the only ones informed of what which group of participants was treated with. The study lasted 67 days, during which the participants in the test group had FulFix® applied to their scalps, and participants in the control group had a placebo ointment applied to their scalps.

The final results estimation showed that the people from the test group (312 people) had an average of 97.8% hair loss reduction rate and an average of 89.9% new hair growth rate. Those in the placebo group (109 people) had an average of 11.3% hair loss aggravation and were continuing to lose hair as before the tests.

FulFix® was proven highly effective in two of the largest clinical studies ever performed on a non-prescription hair loss product that is also 100% natural.